The monthly U.S. budget deficit for June 2020 was a heart-stopping record $864 billion. For reference, last year’s deficit for all of fiscal 2019 was just under $1 trillion. In other words, the June deficit was almost as much as the entire amount of red ink spilled one year ago. This year will see the worst annual amount of fiscal hemorrhaging ever—and by a whole lot. The figure will be at least $4 trillion in total, which is $2.6 trillion more than the peak suffered under the Great Recession. One has to imagine that with the Department of Labor reporting, there are now 32 million people collecting unemployment insurance as of June 27th–the amount of additional debt continues to pile up fast.
By Victor Tangermann – Re-Blogged From Futurism
Pharmaceutical firm Sorrento Therapeutics claims to have found the first ingredient for a “cocktail” of antibodies that could be used to act as a “protective shield” against the coronavirus that causes COVID-19.
In an announcement, the company said it had found a new antibody, called STI-1499, that was able to provide “100% inhibition of SARS-CoV-2 virus infection of healthy cells after four days incubation.”
By Dan Robitzski – Re-Blogged From Futurism
To develop a preventative treatment for the coronavirus, doctors are enlisting thousands of patients who have already recovered.
Or, more specifically, they’re enlisting the coveted antibodies that those patients’ immune systems generated in response to the virus.
- The coronavirus that emerged in Wuhan, China, has mutated and the new, dominant strain spreading across the U.S. appears to be even more contagious, according to a new study.
- The new strain began spreading in Europe in early February before migrating to other parts of the world, including the U.S., becoming the dominant form of the virus across the globe by the end of March, researchers at the Los Alamos National Laboratory wrote.
- If the coronavirus doesn’t subside in the summer like the seasonal flu, it could mutate further and potentially limit the effectiveness of the coronavirus vaccines being developed by scientists, the researchers warned.
By Jonathan Allen – Re-Blogged From IJR
The United States has confirmed 695 measles cases so far this year, the highest level since the country declared it had eliminated the virus in 2000, the U.S. Centers for Disease Control and Prevention said on Wednesday.
The resurgence, which public health officials blamed in part on the spread of misinformation about the safety of vaccines, has been concentrated mainly in Washington state and New York with outbreaks that began late last year.
“The longer these outbreaks continue, the greater the chance measles will again get a sustained foothold in the United States,” the CDC warned in a statement. It said outbreaks can spread out of control in communities with lower-than-normal vaccination rates.
By Kip Hansen – Re-Blogged From WUWT
One hundred years have passed since the Great Influenza Pandemic of 1918 swept around the world, circumnavigating at least twice between 1918 and 1920, killing outright between 50 and 100 million human beings. The pandemic was so shattering, so pervasive that more accurate numbers of the dead cannot be calculated. Those who lived in developed countries like the United States fared little better than those in less developed nations — once the influenza struck, the victim either recovered after a week of unpleasant flu symptoms or died rapidly, sometimes within hours., with lungs filled with fluids and blood. Influenza, caused by a virus, usually kills the very young, the weak and the very old. But the 1918 Flu, sometimes called “the Spanish Flu”, seemed to preferentially kill young, strong, otherwise healthy men and women in their 20’s, a demographic that normally fared well with only mild symptoms in other flu seasons.
By Health Day – Re-Blogged From Newsmax Health
Americans aren’t out of the woods yet, as the flu season continues to spread across the country, health officials reported Friday.
One major shift that’s occurred is in the viruses that are circulating. At the start of the flu season, the predominant strain was influenza A H1N1, but now a more severe strain, influenza A H3N2, accounts for nearly half of all the new cases, according to the U.S. Centers for Disease Control and Prevention.
“It looks like we are moving from an H1 wave to an H3 wave,” said Lynnette Brammer, lead of CDC’s domestic influenza surveillance team. “There’s still a lot of flu to come.”
By Newsmax Health – Re-Blogged From Newsmax
Alzheimer’s disease is expected to affect 14 million Americans by the year 2050, according to the Alzheimer’s Association. While deaths from heart disease have plummeted 11 percent from 2000 to 2015, deaths from Alzheimer’s increased 123 percent during that same time period. According to the Association, 1 in 3 seniors dies with Alzheimer’s.
The dreaded, incurable disease kills people more than breast cancer and prostate cancer combined. That’s why experts were excited when researchers recently announced a potentially effective vaccine for Alzheimer’s. It was developed by a team at the University of Texas Southwestern Medical Center and touted to be able to slash the number of people who are affected by the disease by half.
By DPC – Re-Blogged From Newsmax Health
Doctors can’t yet predict if someone exposed to the flu will become sick. But such predictions may be getting closer to reality, new research hints.
Researchers at Stanford University School of Medicine say they’ve identified a “biomarker” that indicates a person’s susceptibility to flu viruses.
By Vanessa Candeias – Re-Blogged From World Economic Forum
This year marks the 100th anniversary of the deadliest epidemic in history – the 1918 Spanish Influenza outbreak, which killed around 50 million people.
More recently, several outbreaks with equally familiar names have made headlines: SARS, swine flu, MERS, Ebola, Zika, yellow fever, Lassa fever, cholera, drug resistant infections… the list could go on. In fact, every month the World Health Organization receives 5,000 early-warning disease signals from across the globe, around 300 of which need further investigation and of which 30 warrant more in-depth field studies to investigate their potential for causing epidemics.
By Associated Press – Re-Blogged From Newsmax Health
Congo’s Ebola outbreak has spread to a crossroads city of more than 1 million people in a troubling turn that marks the first time the vast, impoverished country has encountered the lethal virus in an urban area.
“This is a major, major game-changer in the outbreak,” Dr. Peter Salama, the World Health Organization’s deputy director-general of emergency preparedness and response, warned on Thursday.
By Associated Press – Re-Blogged From Newsmax Health
The FDA has approved the first drug designed to prevent chronic migraines. Aimovig is injected monthly just under the skin using a pen-like device and will cost $6,900 per year without insurance.
The Food and Drug Administration’s action clears the monthly shot for sale. Aimovig is the first in a new class of long-acting drugs for preventing migraines. Three other shots are expected to win approval by next year, and several pills for preventing migraines are being tested.
By Associated Press – Re-Blogged From Newsmax
For the first time, a treatment that boosts the immune system greatly improved survival in people newly diagnosed with the most common form of lung cancer. It’s the biggest win so far for immunotherapy, which has had much of its success until now in less common cancers.
In the study, Merck’s Keytruda, given with standard chemotherapy, cut in half the risk of dying or having the cancer worsen, compared to chemo alone after nearly one year. The results are expected to quickly set a new standard of care for about 70,000 patients each year in the United States whose lung cancer has already spread by the time it’s found.
By Nick Tate – Re-Blogged From Newsmax Health
Stanford Univesity researchers are recruiting lymphoma patients to test a new cancer vaccine that had a 97 percent success rate in “curing” mice with cancer.
The clinical trial will involve about 15 patients with low-grade lymphoma and begin by the end of the year, according to a Stanford news release.
By Chelsea Gohd – Re-Blogged From Futurism
In Brief: After showing remarkable results in animal models, a new localized immunotherapy that targets the tumor with a simple injection is ready to enter clinical trials.
Researchers at Stanford University have developed a compound that when injected into a tumor destroys it along with all the other cancerous masses present in the body.
By Eric Worrall – Re-Blogged From http://www.WattsUpWithThat.com
This isn’t a climate article, it is about a real problem.
Back in 1918, the infamous flu pandemic killed an estimated 3-5% of the population of the time – 50-100 million people. The awful potential of a new 1918 style flu Pandemic to sweep the world and kill millions, perhaps billions, despite all our medical advances, makes every flicker of infectious ability for novel strains of flu newsworthy.
[Economically important, but I take no position for or against. – Bob]
By Dave Mihalovic – Re-Blogged From PreventDisease.com
A summary review of data on neurological adverse events and the historical role of vaccination in the natural course of infectious disease in Switzerland and Germany, supports data from other regions with evidence that vaccines had no impact on disease prevention efforts from the early-mid to late 20th century. The data contradicts widespread misinformation campaigns by mainstream medicine which claim that vaccination led to immunization and a subsequent decline in infectious disease. The review supports other data around the world and mounting evidence that vaccine effectiveness is unproven, unjustified and lacking evidence-based medicine. The report was authored by the Department of Pediatric Rehabilitation of the Medical University of Bialystok, Poland and published in Progress in Health Sciences a division of The International Journal of Health Sciences.
There is now mass awareness on the dangers of vaccination and only education into the statistical reality of historical immunization efforts and their failure over the last century can validate the growing controversy regarding vaccine effectiveness.